nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—PDE2A—tongue—salivary gland cancer	0.0223	0.115	CbGeAlD
Dipyridamole—PDE6B—connective tissue—salivary gland cancer	0.0152	0.0782	CbGeAlD
Dipyridamole—PDE11A—epithelium—salivary gland cancer	0.0134	0.069	CbGeAlD
Dipyridamole—PDE8B—neck—salivary gland cancer	0.0122	0.0629	CbGeAlD
Dipyridamole—PDE6B—lymphoid tissue—salivary gland cancer	0.0111	0.0572	CbGeAlD
Dipyridamole—PDE7A—lymphoid tissue—salivary gland cancer	0.00922	0.0474	CbGeAlD
Dipyridamole—PDE3B—connective tissue—salivary gland cancer	0.00857	0.0441	CbGeAlD
Dipyridamole—PDE1C—lymph node—salivary gland cancer	0.00733	0.0377	CbGeAlD
Dipyridamole—PRUNE—lymph node—salivary gland cancer	0.00661	0.034	CbGeAlD
Dipyridamole—ADA—connective tissue—salivary gland cancer	0.0065	0.0334	CbGeAlD
Dipyridamole—PDE6D—lymph node—salivary gland cancer	0.00638	0.0328	CbGeAlD
Dipyridamole—PDE6G—lymph node—salivary gland cancer	0.00562	0.0289	CbGeAlD
Dipyridamole—PDE5A—connective tissue—salivary gland cancer	0.00538	0.0277	CbGeAlD
Dipyridamole—PDE5A—epithelium—salivary gland cancer	0.00511	0.0263	CbGeAlD
Dipyridamole—ADA—lymphoid tissue—salivary gland cancer	0.00475	0.0244	CbGeAlD
Dipyridamole—PDE7B—lymph node—salivary gland cancer	0.00455	0.0234	CbGeAlD
Dipyridamole—SLC29A1—connective tissue—salivary gland cancer	0.00452	0.0232	CbGeAlD
Dipyridamole—PDE2A—lymph node—salivary gland cancer	0.0038	0.0195	CbGeAlD
Dipyridamole—PDE10A—lymph node—salivary gland cancer	0.0038	0.0195	CbGeAlD
Dipyridamole—PDE1B—lymph node—salivary gland cancer	0.00376	0.0193	CbGeAlD
Dipyridamole—PDE8B—lymph node—salivary gland cancer	0.00362	0.0186	CbGeAlD
Dipyridamole—PDE3B—lymph node—salivary gland cancer	0.00354	0.0182	CbGeAlD
Dipyridamole—SLC29A1—lymphoid tissue—salivary gland cancer	0.00331	0.017	CbGeAlD
Dipyridamole—PDE8A—lymph node—salivary gland cancer	0.00326	0.0167	CbGeAlD
Dipyridamole—PDE1A—lymph node—salivary gland cancer	0.00315	0.0162	CbGeAlD
Dipyridamole—ADA—lymph node—salivary gland cancer	0.00268	0.0138	CbGeAlD
Dipyridamole—PDE4A—lymph node—salivary gland cancer	0.00261	0.0134	CbGeAlD
Dipyridamole—PDE5A—lymph node—salivary gland cancer	0.00222	0.0114	CbGeAlD
Dipyridamole—PDE3A—lymph node—salivary gland cancer	0.00216	0.0111	CbGeAlD
Dipyridamole—ABCC5—lymph node—salivary gland cancer	0.00203	0.0104	CbGeAlD
Dipyridamole—SLC29A1—lymph node—salivary gland cancer	0.00187	0.00959	CbGeAlD
Dipyridamole—ABCC4—lymph node—salivary gland cancer	0.00141	0.00724	CbGeAlD
Dipyridamole—ABCB1—epithelium—salivary gland cancer	0.00113	0.0058	CbGeAlD
Dipyridamole—ABCB1—lymphoid tissue—salivary gland cancer	0.000869	0.00446	CbGeAlD
Dipyridamole—ABCB1—lymph node—salivary gland cancer	0.00049	0.00252	CbGeAlD
Dipyridamole—PDE1C—Immune System—EP300—salivary gland cancer	0.000112	0.00014	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—EP300—salivary gland cancer	0.000111	0.000138	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—EP300—salivary gland cancer	0.000111	0.000138	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—FBXW7—salivary gland cancer	0.000111	0.000138	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling by GPCR—HRAS—salivary gland cancer	0.00011	0.000136	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling by GPCR—HRAS—salivary gland cancer	0.00011	0.000136	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—FOXO3—salivary gland cancer	0.000109	0.000136	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—MAP2K2—salivary gland cancer	0.000109	0.000136	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—MAP2K2—salivary gland cancer	0.000109	0.000136	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—PTEN—salivary gland cancer	0.000109	0.000135	CbGpPWpGaD
Dipyridamole—PDE6A—Disease—HRAS—salivary gland cancer	0.000109	0.000135	CbGpPWpGaD
Dipyridamole—PDE6B—Disease—HRAS—salivary gland cancer	0.000109	0.000135	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—MAP2K2—salivary gland cancer	0.000108	0.000134	CbGpPWpGaD
Dipyridamole—PDE11A—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000108	0.000134	CbGpPWpGaD
Dipyridamole—PDE7A—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000108	0.000134	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—PTEN—salivary gland cancer	0.000108	0.000134	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—PTEN—salivary gland cancer	0.000107	0.000133	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling by GPCR—HRAS—salivary gland cancer	0.000107	0.000133	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—CREBBP—salivary gland cancer	0.000107	0.000132	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000106	0.000131	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—CREBBP—salivary gland cancer	0.000105	0.000131	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—EP300—salivary gland cancer	0.000104	0.00013	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—EP300—salivary gland cancer	0.000104	0.000129	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—JAG1—salivary gland cancer	0.000104	0.000129	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—FGFR4—salivary gland cancer	0.000103	0.000128	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000103	0.000128	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—EP300—salivary gland cancer	0.000103	0.000128	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—CCND1—salivary gland cancer	0.000103	0.000128	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—CCND1—salivary gland cancer	0.000103	0.000128	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—CREBBP—salivary gland cancer	0.000103	0.000127	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—FOXO3—salivary gland cancer	0.000102	0.000127	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—EP300—salivary gland cancer	0.000102	0.000127	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—FBXW7—salivary gland cancer	0.000102	0.000126	CbGpPWpGaD
Dipyridamole—ABCC4—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000101	0.000125	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.0001	0.000125	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—CCND1—salivary gland cancer	0.0001	0.000124	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—MAP2K2—salivary gland cancer	9.99e-05	0.000124	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—FOXO3—salivary gland cancer	9.97e-05	0.000124	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—PTEN—salivary gland cancer	9.92e-05	0.000123	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—PTEN—salivary gland cancer	9.92e-05	0.000123	CbGpPWpGaD
Dipyridamole—PDE3B—Hemostasis—PIK3CA—salivary gland cancer	9.86e-05	0.000122	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—PTEN—salivary gland cancer	9.86e-05	0.000122	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—PIK3CA—salivary gland cancer	9.82e-05	0.000122	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—PIK3CA—salivary gland cancer	9.82e-05	0.000122	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling by GPCR—HRAS—salivary gland cancer	9.77e-05	0.000121	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—PTEN—salivary gland cancer	9.67e-05	0.00012	CbGpPWpGaD
Dipyridamole—PDE10A—GPCR downstream signaling—PIK3CA—salivary gland cancer	9.63e-05	0.00012	CbGpPWpGaD
Dipyridamole—PDE3B—Hemostasis—TP53—salivary gland cancer	9.54e-05	0.000118	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—EP300—salivary gland cancer	9.46e-05	0.000117	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—EP300—salivary gland cancer	9.46e-05	0.000117	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—EP300—salivary gland cancer	9.4e-05	0.000117	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—FOXO3—salivary gland cancer	9.37e-05	0.000116	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—CREBBP—salivary gland cancer	9.36e-05	0.000116	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—EP300—salivary gland cancer	9.22e-05	0.000114	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—MARCKS—salivary gland cancer	9.17e-05	0.000114	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—CCND1—salivary gland cancer	9.16e-05	0.000114	CbGpPWpGaD
Dipyridamole—PDE3B—Hemostasis—HRAS—salivary gland cancer	9.13e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—PIK3CA—salivary gland cancer	9.1e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—HRAS—salivary gland cancer	9.08e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—HRAS—salivary gland cancer	9.08e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—PIK3CA—salivary gland cancer	8.98e-05	0.000112	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—NOTCH1—salivary gland cancer	8.95e-05	0.000111	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—NOTCH1—salivary gland cancer	8.95e-05	0.000111	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MAP2K2—salivary gland cancer	8.94e-05	0.000111	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—PTEN—salivary gland cancer	8.84e-05	0.00011	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CREBBP—salivary gland cancer	8.79e-05	0.000109	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—PIK3CA—salivary gland cancer	8.75e-05	0.000109	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CDH1—salivary gland cancer	8.73e-05	0.000108	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—TP53—salivary gland cancer	8.69e-05	0.000108	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—FOXO3—salivary gland cancer	8.57e-05	0.000106	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PYGB—salivary gland cancer	8.53e-05	0.000106	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—CCND1—salivary gland cancer	8.52e-05	0.000106	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—CCND1—salivary gland cancer	8.52e-05	0.000106	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—PIK3CA—salivary gland cancer	8.45e-05	0.000105	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—EP300—salivary gland cancer	8.43e-05	0.000105	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—HRAS—salivary gland cancer	8.42e-05	0.000105	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MAP2K2—salivary gland cancer	8.37e-05	0.000104	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—PIK3CA—salivary gland cancer	8.31e-05	0.000103	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—HRAS—salivary gland cancer	8.31e-05	0.000103	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—PIK3CA—salivary gland cancer	8.23e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—PIK3CA—salivary gland cancer	8.23e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—PTEN—salivary gland cancer	8.22e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—PTEN—salivary gland cancer	8.22e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—NOTCH1—salivary gland cancer	8.19e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—TP53—salivary gland cancer	8.17e-05	0.000101	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MAP2K2—salivary gland cancer	8.14e-05	0.000101	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—CREBBP—salivary gland cancer	8.12e-05	0.000101	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—CREBBP—salivary gland cancer	8.12e-05	0.000101	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—HRAS—salivary gland cancer	8.09e-05	0.0001	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CREBBP—salivary gland cancer	8.04e-05	9.98e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CDH1—salivary gland cancer	7.98e-05	9.91e-05	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—TP53—salivary gland cancer	7.96e-05	9.88e-05	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—TP53—salivary gland cancer	7.96e-05	9.88e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—EP300—salivary gland cancer	7.91e-05	9.83e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—CCND1—salivary gland cancer	7.89e-05	9.8e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—EP300—salivary gland cancer	7.84e-05	9.73e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—EP300—salivary gland cancer	7.84e-05	9.73e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—HRAS—salivary gland cancer	7.81e-05	9.7e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—CCND1—salivary gland cancer	7.79e-05	9.67e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—PIK3CA—salivary gland cancer	7.73e-05	9.59e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—HRAS—salivary gland cancer	7.69e-05	9.55e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—PIK3CA—salivary gland cancer	7.68e-05	9.53e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MAP2K2—salivary gland cancer	7.65e-05	9.5e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—PTEN—salivary gland cancer	7.62e-05	9.46e-05	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—HRAS—salivary gland cancer	7.61e-05	9.45e-05	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—HRAS—salivary gland cancer	7.61e-05	9.45e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—PIK3CA—salivary gland cancer	7.6e-05	9.44e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—CCND1—salivary gland cancer	7.59e-05	9.42e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—PIK3CA—salivary gland cancer	7.57e-05	9.4e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—PTEN—salivary gland cancer	7.52e-05	9.33e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—TP53—salivary gland cancer	7.47e-05	9.28e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	7.43e-05	9.23e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—CREBBP—salivary gland cancer	7.42e-05	9.22e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—PTEN—salivary gland cancer	7.33e-05	9.1e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—NOTCH1—salivary gland cancer	7.32e-05	9.09e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—EP300—salivary gland cancer	7.27e-05	9.02e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	7.17e-05	8.91e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—EP300—salivary gland cancer	7.17e-05	8.9e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—HRAS—salivary gland cancer	7.15e-05	8.87e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—HRAS—salivary gland cancer	7.1e-05	8.82e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—HRAS—salivary gland cancer	7.04e-05	8.74e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—HRAS—salivary gland cancer	7.01e-05	8.7e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MAP2K2—salivary gland cancer	7e-05	8.69e-05	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—PIK3CA—salivary gland cancer	7e-05	8.69e-05	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—PIK3CA—salivary gland cancer	7e-05	8.69e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—EP300—salivary gland cancer	6.99e-05	8.67e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—PIK3CA—salivary gland cancer	6.96e-05	8.64e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PHGDH—salivary gland cancer	6.95e-05	8.63e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—NOTCH1—salivary gland cancer	6.85e-05	8.51e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	6.84e-05	8.49e-05	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—PIK3CA—salivary gland cancer	6.82e-05	8.47e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—CREBBP—salivary gland cancer	6.8e-05	8.44e-05	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—TP53—salivary gland cancer	6.77e-05	8.4e-05	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—TP53—salivary gland cancer	6.77e-05	8.4e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ST3GAL4—salivary gland cancer	6.69e-05	8.31e-05	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—PTEN—salivary gland cancer	6.68e-05	8.3e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—NOTCH1—salivary gland cancer	6.67e-05	8.28e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CREBBP—salivary gland cancer	6.64e-05	8.24e-05	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—TP53—salivary gland cancer	6.6e-05	8.19e-05	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—HRAS—salivary gland cancer	6.47e-05	8.04e-05	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—HRAS—salivary gland cancer	6.47e-05	8.04e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—HRAS—salivary gland cancer	6.43e-05	7.99e-05	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—EP300—salivary gland cancer	6.37e-05	7.91e-05	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—HRAS—salivary gland cancer	6.31e-05	7.83e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—PTEN—salivary gland cancer	6.28e-05	7.8e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—NOTCH1—salivary gland cancer	6.27e-05	7.78e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—PIK3CA—salivary gland cancer	6.24e-05	7.74e-05	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—PIK3CA—salivary gland cancer	6.23e-05	7.74e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CREBBP—salivary gland cancer	6.21e-05	7.72e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—AQP1—salivary gland cancer	6.08e-05	7.54e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CREBBP—salivary gland cancer	6.05e-05	7.51e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—TP53—salivary gland cancer	6.03e-05	7.49e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—EP300—salivary gland cancer	5.99e-05	7.43e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—PIK3CA—salivary gland cancer	5.85e-05	7.27e-05	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—PIK3CA—salivary gland cancer	5.84e-05	7.25e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—PIK3CA—salivary gland cancer	5.8e-05	7.2e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—PIK3CA—salivary gland cancer	5.8e-05	7.2e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—PTEN—salivary gland cancer	5.8e-05	7.2e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—PTEN—salivary gland cancer	5.8e-05	7.2e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—HRAS—salivary gland cancer	5.77e-05	7.16e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—PTEN—salivary gland cancer	5.74e-05	7.13e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—NOTCH1—salivary gland cancer	5.73e-05	7.12e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CREBBP—salivary gland cancer	5.68e-05	7.06e-05	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—PIK3CA—salivary gland cancer	5.68e-05	7.05e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—TP53—salivary gland cancer	5.66e-05	7.03e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—PIK3CA—salivary gland cancer	5.66e-05	7.03e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TP53—salivary gland cancer	5.61e-05	6.96e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TP53—salivary gland cancer	5.61e-05	6.96e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—EP300—salivary gland cancer	5.53e-05	6.86e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—EP300—salivary gland cancer	5.53e-05	6.86e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—EP300—salivary gland cancer	5.48e-05	6.8e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—HRAS—salivary gland cancer	5.42e-05	6.73e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—PIK3CA—salivary gland cancer	5.38e-05	6.67e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—HRAS—salivary gland cancer	5.36e-05	6.66e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—HRAS—salivary gland cancer	5.36e-05	6.66e-05	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—PIK3CA—salivary gland cancer	5.34e-05	6.63e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—PIK3CA—salivary gland cancer	5.3e-05	6.58e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—PTEN—salivary gland cancer	5.3e-05	6.58e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—PIK3CA—salivary gland cancer	5.3e-05	6.58e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—HRAS—salivary gland cancer	5.24e-05	6.5e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TP53—salivary gland cancer	5.2e-05	6.46e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CREBBP—salivary gland cancer	5.2e-05	6.45e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—PIK3CA—salivary gland cancer	5.17e-05	6.42e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—PIK3CA—salivary gland cancer	5.16e-05	6.4e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TP53—salivary gland cancer	5.13e-05	6.37e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	5.06e-05	6.28e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—EP300—salivary gland cancer	5.06e-05	6.28e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TP53—salivary gland cancer	5e-05	6.21e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—HRAS—salivary gland cancer	4.97e-05	6.17e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CCND1—salivary gland cancer	4.91e-05	6.1e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—HRAS—salivary gland cancer	4.91e-05	6.09e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—HRAS—salivary gland cancer	4.9e-05	6.09e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	4.9e-05	6.08e-05	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—PIK3CA—salivary gland cancer	4.88e-05	6.06e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PTEN—salivary gland cancer	4.85e-05	6.03e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—PIK3CA—salivary gland cancer	4.85e-05	6.02e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—NUP62—salivary gland cancer	4.82e-05	5.98e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—HRAS—salivary gland cancer	4.78e-05	5.94e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—VCAN—salivary gland cancer	4.78e-05	5.93e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—HRAS—salivary gland cancer	4.77e-05	5.92e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—PTEN—salivary gland cancer	4.74e-05	5.89e-05	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—PIK3CA—salivary gland cancer	4.71e-05	5.85e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—EP300—salivary gland cancer	4.63e-05	5.75e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CCND1—salivary gland cancer	4.6e-05	5.71e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—EP300—salivary gland cancer	4.52e-05	5.61e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—HRAS—salivary gland cancer	4.48e-05	5.57e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CCND1—salivary gland cancer	4.47e-05	5.55e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—PTEN—salivary gland cancer	4.44e-05	5.51e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—PIK3CA—salivary gland cancer	4.43e-05	5.5e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—PIK3CA—salivary gland cancer	4.43e-05	5.5e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—PTEN—salivary gland cancer	4.32e-05	5.36e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—EP300—salivary gland cancer	4.23e-05	5.26e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CCND1—salivary gland cancer	4.21e-05	5.22e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—EP300—salivary gland cancer	4.12e-05	5.11e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—HRAS—salivary gland cancer	4.1e-05	5.09e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—HRAS—salivary gland cancer	4.1e-05	5.09e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—PIK3CA—salivary gland cancer	4.09e-05	5.08e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—PIK3CA—salivary gland cancer	4.09e-05	5.08e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PTEN—salivary gland cancer	4.06e-05	5.04e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—PIK3CA—salivary gland cancer	4.05e-05	5.03e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	3.99e-05	4.95e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—EP300—salivary gland cancer	3.87e-05	4.81e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CCND1—salivary gland cancer	3.85e-05	4.78e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—HRAS—salivary gland cancer	3.78e-05	4.7e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—HRAS—salivary gland cancer	3.78e-05	4.7e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—HRAS—salivary gland cancer	3.75e-05	4.65e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—PIK3CA—salivary gland cancer	3.74e-05	4.64e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PTEN—salivary gland cancer	3.71e-05	4.61e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—EP300—salivary gland cancer	3.54e-05	4.4e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—HRAS—salivary gland cancer	3.46e-05	4.3e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PIK3CA—salivary gland cancer	3.42e-05	4.25e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—PIK3CA—salivary gland cancer	3.34e-05	4.15e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TP53—salivary gland cancer	3.24e-05	4.02e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—PIK3CA—salivary gland cancer	3.13e-05	3.89e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—HRAS—salivary gland cancer	3.09e-05	3.84e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—PIK3CA—salivary gland cancer	3.05e-05	3.78e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TP53—salivary gland cancer	3.03e-05	3.76e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TP53—salivary gland cancer	2.95e-05	3.66e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—HRAS—salivary gland cancer	2.9e-05	3.6e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PIK3CA—salivary gland cancer	2.86e-05	3.56e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—HRAS—salivary gland cancer	2.82e-05	3.5e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TP53—salivary gland cancer	2.77e-05	3.44e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—HRAS—salivary gland cancer	2.65e-05	3.29e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PIK3CA—salivary gland cancer	2.62e-05	3.25e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TP53—salivary gland cancer	2.53e-05	3.15e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—HRAS—salivary gland cancer	2.42e-05	3.01e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CREBBP—salivary gland cancer	1.87e-05	2.32e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PTEN—salivary gland cancer	1.33e-05	1.66e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—EP300—salivary gland cancer	1.27e-05	1.58e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PIK3CA—salivary gland cancer	9.41e-06	1.17e-05	CbGpPWpGaD
